Concepedia

Mark J. Sartain

MJ

9

Publications

745

Citations

9

H-Index

2006

Active since

Affiliations

Agilent Technologies (United States)(Current)

Institute for Systems Biology

Colorado State University

Center for Infectious Disease Research

Mark J. Sartain is an author at Agilent Technologies (United States) specializing in biochemistry, mass spectrometry, and medicine.

Top concepts

Publications per year

2006–2021

9

Publications

9

ATF3 protects against atherosclerosis by suppressing 25-hydroxycholesterol–induced lipid body formation

Elizabeth S. Gold, Stephen A. Ramsey, Mark J. Sartain et al. · The Journal of Experimental Medicine · 2012 · 150 citations · Full text

Lipidomic analyses of Mycobacterium tuberculosis based on accurate mass measurements and the novel “Mtb LipidDB”

Mark J. Sartain, Donald L. Dick, Christopher D. Rithner et al. · Journal of Lipid Research · 2011 · 149 citations · Full text

Lipid Annotator: Towards Accurate Annotation in Non-Targeted Liquid Chromatography High-Resolution Tandem Mass Spectrometry (LC-HRMS/MS) Lipidomics Using a Rapid and User-Friendly Software

Jeremy P. Koelmel, Xiangdong Li, Sarah M. Stow et al. · Metabolites · 2020 · 114 citations · Full text

, , +18

Disease State Differentiation and Identification of Tuberculosis Biomarkers via Native Antigen Array Profiling

Mark J. Sartain, Richard A. Slayden, Krishna K. Singh et al. · Molecular & Cellular Proteomics · 2006 · 103 citations · Full text

N-Terminal clustering of the O-glycosylation sites in the Mycobacterium tuberculosis lipoprotein SodC

Mark J. Sartain, John T. Belisle · Glycobiology · 2008 · 57 citations · Full text

, , +15

Rows per page

1–5 of 9